[ad_1] ARTES Biotechnology, a biotechnology company specializing in the development of processes for recombinant vaccines, entered the development of SARS-CoV-2 vaccine candidates based on its platform technologies based on virus-like particle (VLP) METAVAX and SplitCore. METAVAX is a platform for the development of vaccines based on enveloped virus-like particle nanostructures …
Read More »ARTES Biotech will develop VLP SARS-CoV-2 Vax candidates
